Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Willemze R, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kempf W, Zimmermann AK, Mitteldorf C. Cutaneous lymphomas: an update 2019. Hematol Oncol. 2019;37(Suppl. 1):43–7.

PubMed  Article  Google Scholar 

Hope CB, Pincus LB. Primary cutaneous B-cell lymphomas. Clin Lab Med. 2017;37(3):547–74.

PubMed  Article  Google Scholar 

National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology, primary cutaneous B-cell lymphomas version 2.2021. Fort Washington: National Comprehensive Cancer Network; 2021.

Google Scholar 

Tadiotto Cicogna G, Ferranti M, Alaibac M. Diagnostic workup of primary cutaneous B cell lymphomas: a clinician’s approach. Front Oncol. 2020;10:988.

PubMed  PubMed Central  Article  Google Scholar 

Kim YH, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(2):479–84.

CAS  PubMed  Article  Google Scholar 

Senff NJ, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma. Consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600–9.

CAS  PubMed  Article  Google Scholar 

Vitiello P, et al. Primary cutaneous B-cell lymphomas: an update. Front Oncol. 2020;10:651.

PubMed  PubMed Central  Article  Google Scholar 

Dumont M, Battistella M, Ram-Wolff C, Bagot M, de Masson A. Diagnosis and treatment of primary cutaneous B-cell lymphomas: state of the art and perspectives. Cancers (Basel). 2020;12(6):1497.

CAS  PubMed Central  Article  Google Scholar 

Swerdlow SH. Cutaneous marginal zone lymphomas. Semin Diagn Pathol. 2017;34(1):76–84.

PubMed  Article  Google Scholar 

Amitay-Laish I, et al. Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart? Br J Dermatol. 2017;176(4):1010–20.

CAS  PubMed  Article  Google Scholar 

Guitart J, et al. High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas. JAMA Dermatol. 2014;150(4):412–8.

PubMed  Article  Google Scholar 

Li C, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases. Am J Surg Pathol. 2003;27(8):1061–9.

PubMed  Article  Google Scholar 

Bailey EM, et al. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol. 1996;20(8):1011–23.

CAS  PubMed  Article  Google Scholar 

Magro CM, Yang A, Fraga G. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature. Am J Dermatopathol. 2013;35(3):319–26.

PubMed  Article  Google Scholar 

Cerroni L, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol. 1997;21(11):1307–15.

CAS  PubMed  Article  Google Scholar 

Hoefnagel JJ, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood. 2005;105(9):3671–8.

CAS  PubMed  Article  Google Scholar 

Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997;24(8):457–61.

CAS  PubMed  Article  Google Scholar 

Wood GS, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol. 2001;28(10):502–7.

CAS  PubMed  Article  Google Scholar 

Mandekou-Lefaki I, Delli FS, Kountouras J, Athanasiou E, Mattheou-Vakali G. Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship. J Eur Acad Dermatol Venereol. 2006;20(5):606–8.

CAS  PubMed  Article  Google Scholar 

May SA, Netto G, Domiati-Saad R, Kasper C. Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination. J Am Acad Dermatol. 2005;53(3):512–6.

PubMed  Article  Google Scholar 

Takino H, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol. 2008;21(12):1517–26.

CAS  PubMed  Article  Google Scholar 

Guastafierro S, et al. Clinical significance of serum triple monoclonal components: a report of 6 cases and a review of the literature. Leuk Res. 2014;38(2):166–9.

PubMed  Article  Google Scholar 

Guastafierro S, et al. Serum double monoclonal components and hematological malignancies: only a casual association? Review of 34 cases. Leuk Res. 2012;36(10):1274–7.

PubMed  Article  Google Scholar 

Chen ST, Barnes J, Duncan L. Primary cutaneous B-cell lymphomas: clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018;37(1):49–55.

PubMed  Article  Google Scholar 

Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010;34(12):1830–41.

PubMed  Article  Google Scholar 

van Maldegem F, et al. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood. 2008;112(8):3355–61.

PubMed  Article  CAS  Google Scholar 

Carlsen ED, Swerdlow SH, Cook JR, Gibson SE. Class-switched primary cutaneous marginal zone lymphomas are frequently IgG4-positive and have features distinct from IgM-positive cases. Am J Surg Pathol. 2019;43(10):1403–12.

PubMed  Article  Google Scholar 

Sun JR, Nong L, Liu XQ, Tu P, Wang Y. Frequent immunoglobulin G4 expression in a common variant of primary cutaneous marginal zone B-cell lymphoma. Australas J Dermatol. 2018;59(2):141–5.

PubMed  Article  Google Scholar 

Machan S, et al. Primary cutaneous marginal IgG4 lymphoma and Rosai-Dorfman’s disease coexisting in several lesions of the same patient. Am J Dermatopathol. 2015;37(5):413–8.

PubMed  Article  Google Scholar 

Carlsen ED, Bhavsar S, Cook JR, Swerdlow SH. IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression. J Cutan Pathol. 2022;49(1):55–60.

PubMed  Article  Google Scholar 

Servitje O, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol. 2002;147(6):1147–58.

CAS  PubMed  Article  Google Scholar 

Maurus K, et al. Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J Invest Dermatol. 2018;138(7):1573–81.

CAS  PubMed  Article  Google Scholar 

Lukowsky A, Marchwat M, Sterry W, Gellrich S. Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma. 2006;7(3):487–93.

Article  CAS  Google Scholar 

Streubel B, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia. 2004;18(10):1722–6.

CAS  PubMed  Article  Google Scholar 

Hristov AC, Tejasvi T, Wilcox RA. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol. 2020;95:1209–13.

Article  Google Scholar 

Legrand A, et al. Lack of clinical relevance of blood clonality in primary cutaneous marginal zone B-cell lymphoma. Eur J Dermatol. 2021;31(1):94–6.

PubMed  Article  Google Scholar 

Oertel M, Elsayad K, Weishaupt C, Steinbrink K, Eich HT. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma. Strahlenther Onkol. 2020;196(2):126–31.

PubMed  Article  Google Scholar 

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M. Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl. 4):iv30-40.

CAS  PubMed  Article  Google Scholar 

Farkas A, Kemeny L, French LE, Dummer R. New and experimental skin-directed therapies for cutaneous lymphomas. Skin Pharmacol Physiol. 2009;22(6):322–34.

CAS  PubMed  Article  Google Scholar 

Cozzio A, et al. Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma. 2006;47(5):865–9.

CAS  PubMed  Article